IPO Comments on Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights
IPO Comments on Draft Interagency Guidance Framework for Considering the [...]
IPO Comments Regarding FTC’s Petition for Rulemaking of PIRG and iFixit
IPO Comments Regarding FTC's Petition for Rulemaking of PIRG and [...]
IPO 2024 Special 301 Review Comments
IPO 2024 Special 301 Review Comments
IPO’s Notice of Intent to Testify and Hearing Statement re: 2024 Special 301
IPO's Notice of Intent to Testify and Hearing Statement re: [...]
IPO’s Comments to Department of Health and Human Services Re: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement
IPO's Comments to Department of Health and Human Services Re: [...]
IPO Comments to USPTO on WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge
IPO Comments to USPTO on WIPO IGC Negotiations on Genetic [...]
IPO Comments to the U.S. Copyright Office re: Artificial Intelligence and Copyright
IPO Comments to the U.S. Copyright Office re: Artificial Intelligence [...]
IPO Comments Regarding Revision of India’s Manual of Designs Practice and Procedure
IPO Comments Regarding Revision of India’s Manual of Designs Practice [...]
Comments to the USPTO on Changes to Duration of Trademark Attorney Recognition
IPO Comments to the USPTO on Changes to Duration of [...]
IPO Comments to USTR Regarding 2023 Notorious Markets
IPO Comments to USTR Regarding 2023 Notorious Markets
Posts tagged here will show on the testimony and comments page.